BG
TNDM icon

Bellevue Group’s Tandem Diabetes Care TNDM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-782,456
Closed -$28.2M 165
2024
Q4
$28.2M Sell
782,456
-1,068,435
-58% -$38.5M 0.54% 45
2024
Q3
$78.5M Buy
1,850,891
+307,624
+20% +$13M 1.27% 23
2024
Q2
$62.2M Sell
1,543,267
-488,621
-24% -$19.7M 1.01% 25
2024
Q1
$71.9M Buy
2,031,888
+39,571
+2% +$1.4M 1.1% 25
2023
Q4
$58.9M Sell
1,992,317
-150,452
-7% -$4.45M 0.9% 33
2023
Q3
$44.5M Buy
2,142,769
+49,835
+2% +$1.04M 0.72% 41
2023
Q2
$51.4M Buy
2,092,934
+299,171
+17% +$7.34M 0.73% 43
2023
Q1
$72.8M Buy
1,793,763
+2,313
+0.1% +$93.9K 1.06% 32
2022
Q4
$80.5M Buy
1,791,450
+225,435
+14% +$10.1M 1.07% 26
2022
Q3
$74.9M Buy
1,566,015
+250,142
+19% +$12M 1.08% 31
2022
Q2
$77.9M Buy
1,315,873
+199,365
+18% +$11.8M 1.1% 28
2022
Q1
$130M Buy
1,116,508
+167,251
+18% +$19.4M 1.51% 16
2021
Q4
$143M Sell
949,257
-85,262
-8% -$12.8M 1.47% 17
2021
Q3
$124M Buy
1,034,519
+14,151
+1% +$1.69M 1.25% 23
2021
Q2
$99.4M Buy
1,020,368
+493,234
+94% +$48M 0.97% 30
2021
Q1
$46.5M Buy
527,134
+141,950
+37% +$12.5M 0.49% 63
2020
Q4
$36.9M Buy
385,184
+71,740
+23% +$6.86M 0.42% 69
2020
Q3
$35.6M Buy
313,444
+81,605
+35% +$9.26M 0.49% 58
2020
Q2
$22.9M Buy
231,839
+36,801
+19% +$3.64M 0.32% 73
2020
Q1
$12.6M Sell
195,038
-5,109
-3% -$329K 0.24% 76
2019
Q4
$11.9M Buy
200,147
+5,411
+3% +$323K 0.19% 83
2019
Q3
$11.5M Buy
194,736
+26,889
+16% +$1.59M 0.21% 79
2019
Q2
$10.8M Buy
167,847
+40,306
+32% +$2.6M 0.18% 81
2019
Q1
$8.1M Buy
127,541
+28,288
+29% +$1.8M 0.45% 63
2018
Q4
$3.77M Buy
99,253
+2,058
+2% +$78.2K 0.25% 78
2018
Q3
$4.16M Sell
97,195
-16,811
-15% -$720K 0.26% 80
2018
Q2
$2.51M Buy
+114,006
New +$2.51M 0.21% 79